Upper Street Marketing to Grow 300 Acres of Hemp and Extract CBD in 2019 and up to 7,000 Acres in 2020

San Diego, California--(Newsfile Corp. - May 7, 2019) - Upper Street Marketing Inc. (OTC Pink: UPPR) and its wholly-owned subsidiary, Growing Springs Holding Corporation, are pleased to announce that it has completed assembling all the resources for planting and nutrition for our hemp crop of 300 acres for crop year 2019. The acreage in question is certified organic. CBD yields through extraction may exceed $200,000 per acre at current wholesale pricing.

Upper Street Marketing Inc., through its wholly owned subsidiary Growing Springs Holdings Corporation, has an experienced cultivation team led by Roger Christensen of Center, Colorado. Mr. Christensen has over 25 years-experience in organic farming and product distribution.

Based on the 2019 crop estimates, UPPR expects harvest and CBD extraction in late September or early October. UPPR extraction with its pharmaceutical partner, PrimaPharma Inc., of San Diego, CA will target revenue in excess of $75 million in CBD extracts for 2019.

Upper Street CEO Joseph Earle stated, "Upper Street is now positioned for significant revenue growth for 2019 and we are already planning on expanding our hemp crops and CBD extraction by growing approximately 7,000 acres of hemp in 2020."

Further to our news release of April 25, 2019, below is a corporate update.

We embarked on an ambitious plan in 2018 to become the first and likely the largest cGMP CBD producer and marketing company in the United States and a major player in the global market for what we see as the most significant new market in many years.

In a recent Fortune Magazine article, dated February 25th, 2019 they quoted a news analysis by Cowen & Co, nearly 7% of Americans are already using cannabidiol (CBD), placing the potential for the much-hyped cannabis compound at $35 Billion by 2025. They went on to say that they "conservatively" see CBD use growing to 30% CAGR of U.S. adults or 25 million consumers by 2025.

CBD is promoted as an effective treatment for everything from arthritis to insomnia. To date, the only FDA approved uses are for two rare forms of childhood epilepsy. We at UPPR see this changing and UPPR, through its wholly owned subsidiary, is at the forefront of this change. UPPR intends to be a leader in FDA cGMP (Current Good Manufacturing Practice) capabilities in the hemp and CBD marketplace. FDA cGMP standards are US requirements that will become the expected manufacturing requirements for all CBD products in the US. UPPR will be at the forefront of this trend and back it up with our strategic partnership with Primapharma Inc. (www.primapharma.net) which we announced on January 22, 2019, to develop fully cGMP CBD oils and isolate, as well as research and clinical studies. UPPR intends to be the industry leader in FDA cGMP standards.

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend", and similar expressions, as they relate to the Company or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about the Company's business, based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Such statements could be affected by risks and uncertainties related to: (i) our ability to execute the Company's business plans with the uncertainty of agricultural crops (ii) product demand, market, and customer acceptance of the Company's products, (iii) the Company's ability to obtain financing to expand our operations, (iv) the Company's ability to attract qualified sales representatives, (v) competition, pricing and development difficulties, (vi) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to the Company's products, (vii) the Company's ability to conduct operations if it faces product recalls, and (viii) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release.

For Further Information Contact:
Upper Street Marketing Inc.: .
Phone: (844) 535-UPPR (8777)

Email: investorrelations@upperstreetmarketing.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/44587

info